NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents.
Saved in:
| Title: | NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents. |
|---|---|
| Authors: | Laskin, J.1 jlaskin@bccancer.bc.ca, Liu, S.V.1,2, Tolba, K.3, Heining, C.4,5,6, Schlenk, R.F.7, Cheema, P.8, Cadranel, J.9, Jones, M.R.10, Drilon, A.11, Cseh, A.12, Gyorffy, S.13, Solca, F.14, Duruisseaux, M.15 |
| Source: | Annals of Oncology. Dec2020, Vol. 31 Issue 12, p1693-1703. 11p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 152685512 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Laskin%2C+J%2E%22">Laskin, J.</searchLink><relatesTo>1</relatesTo><i> jlaskin@bccancer.bc.ca</i><br /><searchLink fieldCode="AR" term="%22Liu%2C+S%2EV%2E%22">Liu, S.V.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Tolba%2C+K%2E%22">Tolba, K.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Heining%2C+C%2E%22">Heining, C.</searchLink><relatesTo>4,5,6</relatesTo><br /><searchLink fieldCode="AR" term="%22Schlenk%2C+R%2EF%2E%22">Schlenk, R.F.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Cheema%2C+P%2E%22">Cheema, P.</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Cadranel%2C+J%2E%22">Cadranel, J.</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Jones%2C+M%2ER%2E%22">Jones, M.R.</searchLink><relatesTo>10</relatesTo><br /><searchLink fieldCode="AR" term="%22Drilon%2C+A%2E%22">Drilon, A.</searchLink><relatesTo>11</relatesTo><br /><searchLink fieldCode="AR" term="%22Cseh%2C+A%2E%22">Cseh, A.</searchLink><relatesTo>12</relatesTo><br /><searchLink fieldCode="AR" term="%22Gyorffy%2C+S%2E%22">Gyorffy, S.</searchLink><relatesTo>13</relatesTo><br /><searchLink fieldCode="AR" term="%22Solca%2C+F%2E%22">Solca, F.</searchLink><relatesTo>14</relatesTo><br /><searchLink fieldCode="AR" term="%22Duruisseaux%2C+M%2E%22">Duruisseaux, M.</searchLink><relatesTo>15</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Dec2020, Vol. 31 Issue 12, p1693-1703. 11p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152685512 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2020.08.2335 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 11 StartPage: 1693 Titles: – TitleFull: NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Laskin, J. – PersonEntity: Name: NameFull: Liu, S.V. – PersonEntity: Name: NameFull: Tolba, K. – PersonEntity: Name: NameFull: Heining, C. – PersonEntity: Name: NameFull: Schlenk, R.F. – PersonEntity: Name: NameFull: Cheema, P. – PersonEntity: Name: NameFull: Cadranel, J. – PersonEntity: Name: NameFull: Jones, M.R. – PersonEntity: Name: NameFull: Drilon, A. – PersonEntity: Name: NameFull: Cseh, A. – PersonEntity: Name: NameFull: Gyorffy, S. – PersonEntity: Name: NameFull: Solca, F. – PersonEntity: Name: NameFull: Duruisseaux, M. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: Dec2020 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 31 – Type: issue Value: 12 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |